Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,472.00
Bid: 12,492.00
Ask: 12,496.00
Change: 74.00 (0.60%)
Spread: 4.00 (0.032%)
Open: 12,432.00
High: 12,526.00
Low: 12,318.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

In Senegal, lack of cold storage limits COVID vaccine options

Mon, 11th Jan 2021 17:09

By Christophe Van Der Perre

DAKAR, Jan 11 (Reuters) - Senegal does not have the capacity
to store COVID-19 vaccines at ultra-low temperatures and would
prefer to receive vials that can be kept for longer under
ordinary refrigeration, the head of the country's vaccination
programme said on Monday.

A lack of cold storage means Senegal would only be able to
keep vaccines developed by AstraZeneca and Oxford
University, by China or Russia in the long term, as they do not
require a deep freeze, Ousseynou Badiane told Reuters.

Those being distributed by Moderna, which require
storage at minus 20 degrees Celsius (-4 F), and Pfizer
and BioNTech, which need to be kept at -70 degrees
Celsius, are less desirable. Senegal could store the Moderna
vaccine for 30 days and the Pfizer one for seven days but after
that they would be spoiled, Badiane added.

The Moderna and Pfizer vaccines "are not our first choice.
Our first choice is the vaccine that fits easily into the system
that exists, that doesn't require major investment," Badiane
told Reuters.

"If the vaccines are not used (in the right time frame) that
would be an enormous waste."

The situation in Senegal highlights the problems that poorer
countries with hot climates face in storing and distributing
vaccines, often in rural areas with unreliable power supplies.

It also shows how far behind some African countries are in
preparing to receive vaccines even as COVID-19 cases surge to
record levels.

Millions have already received inoculations in Western
countries and China, while Senegal is awaiting vaccines through
the World Health Organization-backed global COVAX scheme. This
programme is helping to finance deliveries to 92 developing
nations with limited or no means to buy vaccines on their own.

Senegal is no stranger to vaccination campaigns.

In four walk-in cold rooms in the capital Dakar, authorities
keep thousands of vials of yellow fever and hepatitis B vaccines
at between 2 and 8 degrees Celsius. It has one room that keeps
oral polio vaccines up to minus 25 degrees Celsius.

At the Fann hospital in Dakar, technicians are installing
seven new such rooms. But for now the lack of deep refrigeration
limits the country's options.

"If the option now is to take the (Pfizer or Moderna)
vaccines we... would have to redo all our logistics," Badiane
said.
(Writing by Edward McAllister;
Editing by Hereward Holland and Gareth Jones)

More News
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.